[Structural basis of alpha-tocopherol succinate as an antineoplastic agent]
1School of Public Health, Harbin Medical University, Harbin 150001, China.
Wei Sheng Yan Jiu = Journal of Hygiene Research
|October 6, 2004
Summary
Alpha-tocopherol succinate, a vitamin E analog, shows significant antineoplastic activity unlike its parent compound. This review explores the structural basis for its cancer-fighting properties, offering new therapeutic insights.
Area of Science:
- Biochemistry
- Pharmacology
- Oncology
Background:
- Alpha-tocopherol succinate is a derivative of alpha-tocopherol, the primary form of vitamin E.
- Unlike alpha-tocopherol, alpha-tocopherol succinate exhibits potent antineoplastic (anti-cancer) effects.
- This activity is independent of the antioxidant properties typically associated with vitamin E.
Purpose of the Study:
- To review and analyze the relationship between the chemical structure of alpha-tocopherol succinate and its observed antineoplastic activity.
- To highlight alpha-tocopherol succinate as a promising pro-vitamin E compound with distinct therapeutic potential.
Main Methods:
- Literature review of existing research on alpha-tocopherol succinate.
- Analysis of structure-activity relationships based on published data.
- Synthesis of findings regarding antineoplastic mechanisms.
Main Results:
- Alpha-tocopherol succinate's unique structure confers redox-silent properties.
- Specific structural features are directly linked to its ability to inhibit cancer cell growth.
- The antineoplastic activity is distinct from the antioxidant functions of alpha-tocopherol.
Conclusions:
- The structural configuration of alpha-tocopherol succinate is critical for its anti-cancer efficacy.
- Understanding these structure-activity relationships can guide the development of novel cancer therapies.
- Alpha-tocopherol succinate represents a promising therapeutic agent in oncology.
Related Concept Videos
01:46Electron Transport Chain: Complex I and II
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:00Drug Toxicity: Overview
Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
01:25Bioactivation and Tissue Toxicity
Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...